Skip to main content
logo
Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.700
-0.050 (-1.82%)
At close: Sep 25, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
After-hours: Sep 25, 2026, 7:40 PM EDT

Zentalis Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--67.43---
Revenue Growth
------
Gross Profit
--67.43---
Operating Income
-150.39-140.88-187.46-248.99-227.29-207.74
Net Income
-139.55-137.06-165.84-292.19-236.81-158.73
Earnings Per Share
-1.96-1.91-2.33-4.47-4.48-3.72
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
174.61245.89371.08482.92437.37339.89
Total Debt
37.6939.5842.6545.7747.3345.91
Net Cash (Debt)
136.92206.32328.44437.15390.04293.98
Net Cash Growth
-47.76%-37.18%-24.87%12.08%32.68%-12.64%
Net Cash Per Share
1.922.874.626.687.386.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-128.1-125.25-170.86-207.82-163.75-154.09
Capital Expenditures
-0.03--0.22-0.58-2.55-6.11
Free Cash Flow
-128.13-125.25-171.08-208.41-166.3-160.2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%---
Operating Margin
---278.02%---
Pretax Margin
---245.74%---
Profit Margin
---245.96%---
FCF Margin
---253.74%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--3.20---